SAG
AMGN icon

SageView Advisory Group’s Amgen AMGN Stock Holding History

SageView Advisory Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.87M Sell
5,717
-234
-4% -$74.2K 0.06% 157
2025
Q3 		$1.68M Sell
5,951
-2,512
-30% -$729K 0.06% 187
2025
Q2 		$2.55M Sell
8,463
-274
-3% -$77.6K 0.1% 118
2025
Q1 		$2.72M Sell
8,737
-51
-0.6% -$15.1K 0.12% 99
2024
Q4 		$2.29M Sell
8,788
-482
-5% -$143K 0.1% 113
2024
Q3 		$2.99M Sell
9,270
-1,004
-10% -$328K 0.15% 83
2024
Q2 		$3.21M Buy
10,274
+1,323
+15% +$389K 0.15% 84
2024
Q1 		$2.55M Sell
8,951
-701
-7% -$205K 0.13% 98
2023
Q4 		$3.04M Buy
9,652
+1,668
+21% +$454K 0.13% 98
2023
Q3 		$2.15M Buy
7,984
+2,317
+41% +$578K 0.12% 106
2023
Q2 		$1.26M Buy
5,667
+245
+5% +$56.8K 0.07% 186
2023
Q1 		$1.31M Buy
5,422
+72
+1% +$17.7K 0.08% 164
2022
Q4 		$1.41M Buy
+5,350
New +$1.43M 0.11% 125

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

SageView Advisory Group's AMGN Position: Q4 2025 in Review

SageView Advisory Group reduced its Amgen (AMGN) stake by 3.9% in Q4 2025, selling an estimated $74.2K and leaving 5,717 shares worth $1.87M. The position accounts for 0.06% of the portfolio, ranked #157.

SageView Advisory Group first reported a position in AMGN in Q4 2022 and has held it in 13 quarters since. The position peaked at $3.21M in Q2 2024. 3,085 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • SageView Advisory Group held 5,717 shares of Amgen worth $1.87M as of Q4 2025.
  • SageView Advisory Group sold 234 Amgen shares in Q4 2025, an estimated $74.2K.
  • Amgen made up 0.06% of SageView Advisory Group's portfolio in Q4 2025, its #157 holding.
  • SageView Advisory Group first reported a position in Amgen in Q4 2022 and has held it in 13 quarters since.
  • SageView Advisory Group's Amgen position peaked at $3.21M in Q2 2024.
  • 3,085 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on SageView Advisory Group's 13F filing for Q4 2025, filed 17 Feb 2026.